.png)
THE STATUS QUO
Resections Fall Short.
Resections are the most common treatment for cancer, but they face re-excision rates of 30-50%. While every cancer cell can increase these odds, surgeons can't see cancer on the cellular level.
Mechanism of Action
THE TECHNOLOGY
Run By Microscopy,
Powered By AI.
LightIR is the world's first device that combines microscopy with deep learning, letting it condense the diagnostic accuracy of pathology labs into a handheld probe. It is expected to head to market by 2023.
Mechanism of Action
.svg)
.svg)
